nodes	percent_of_prediction	percent_of_DWPC	metapath
Butenafine—SQLE—SREBP signalling—RNF139—kidney cancer	0.245	0.38	CbGpPWpGaD
Butenafine—SQLE—Statin Pathway—SCARB1—kidney cancer	0.0856	0.133	CbGpPWpGaD
Butenafine—SQLE—SREBP signalling—SCARB1—kidney cancer	0.0428	0.0665	CbGpPWpGaD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.018	0.028	CbGpPWpGaD
Butenafine—SQLE—SREBP signalling—MTOR—kidney cancer	0.0164	0.0255	CbGpPWpGaD
Butenafine—Erythema—Temsirolimus—kidney cancer	0.0163	0.0458	CcSEcCtD
Butenafine—Dysgeusia—Temsirolimus—kidney cancer	0.016	0.0449	CcSEcCtD
Butenafine—Erythema—Pazopanib—kidney cancer	0.0154	0.0432	CcSEcCtD
Butenafine—Dysgeusia—Pazopanib—kidney cancer	0.015	0.0423	CcSEcCtD
Butenafine—Erythema—Everolimus—kidney cancer	0.0121	0.0341	CcSEcCtD
Butenafine—Dysgeusia—Everolimus—kidney cancer	0.0119	0.0334	CcSEcCtD
Butenafine—Erythema—Erlotinib—kidney cancer	0.0117	0.0329	CcSEcCtD
Butenafine—SQLE—Metabolism—ACY1—kidney cancer	0.0116	0.018	CbGpPWpGaD
Butenafine—Pain—Temsirolimus—kidney cancer	0.0114	0.032	CcSEcCtD
Butenafine—Pain—Pazopanib—kidney cancer	0.0107	0.0301	CcSEcCtD
Butenafine—Erythema—Sorafenib—kidney cancer	0.0105	0.0296	CcSEcCtD
Butenafine—Dysgeusia—Sorafenib—kidney cancer	0.0103	0.029	CcSEcCtD
Butenafine—Stinging—Doxorubicin—kidney cancer	0.0102	0.0286	CcSEcCtD
Butenafine—Erythema—Sunitinib—kidney cancer	0.0101	0.0285	CcSEcCtD
Butenafine—SQLE—SREBP signalling—PIK3CA—kidney cancer	0.00999	0.0155	CbGpPWpGaD
Butenafine—Dysgeusia—Sunitinib—kidney cancer	0.00992	0.0279	CcSEcCtD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00986	0.0153	CbGpPWpGaD
Butenafine—SQLE—Metabolism—PDHB—kidney cancer	0.00983	0.0153	CbGpPWpGaD
Butenafine—Erythema—Dactinomycin—kidney cancer	0.00959	0.0269	CcSEcCtD
Butenafine—Pruritus—Temsirolimus—kidney cancer	0.00941	0.0264	CcSEcCtD
Butenafine—SQLE—Metabolism—CCBL1—kidney cancer	0.00925	0.0144	CbGpPWpGaD
Butenafine—Pruritus—Pazopanib—kidney cancer	0.00887	0.0249	CcSEcCtD
Butenafine—Pain—Vinblastine—kidney cancer	0.00849	0.0239	CcSEcCtD
Butenafine—Pain—Everolimus—kidney cancer	0.00846	0.0238	CcSEcCtD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00836	0.013	CbGpPWpGaD
Butenafine—Pain—Erlotinib—kidney cancer	0.00816	0.0229	CcSEcCtD
Butenafine—Dermatitis contact—Doxorubicin—kidney cancer	0.00814	0.0229	CcSEcCtD
Butenafine—Erythema—Gemcitabine—kidney cancer	0.00813	0.0228	CcSEcCtD
Butenafine—SQLE—Metabolism—PPAT—kidney cancer	0.00802	0.0125	CbGpPWpGaD
Butenafine—SQLE—Metabolism—GLIPR1—kidney cancer	0.00802	0.0125	CbGpPWpGaD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.00791	0.0123	CbGpPWpGaD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00784	0.0122	CbGpPWpGaD
Butenafine—SQLE—Metabolism—APRT—kidney cancer	0.00745	0.0116	CbGpPWpGaD
Butenafine—SQLE—Metabolism—FH—kidney cancer	0.00745	0.0116	CbGpPWpGaD
Butenafine—Pain—Sorafenib—kidney cancer	0.00735	0.0206	CcSEcCtD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00728	0.0113	CbGpPWpGaD
Butenafine—Pain—Sunitinib—kidney cancer	0.00707	0.0199	CcSEcCtD
Butenafine—SQLE—Metabolism—GPC3—kidney cancer	0.00701	0.0109	CbGpPWpGaD
Butenafine—Pruritus—Everolimus—kidney cancer	0.007	0.0197	CcSEcCtD
Butenafine—SQLE—Metabolism—CA2—kidney cancer	0.00682	0.0106	CbGpPWpGaD
Butenafine—Erythema—Paclitaxel—kidney cancer	0.0068	0.0191	CcSEcCtD
Butenafine—Pruritus—Erlotinib—kidney cancer	0.00675	0.019	CcSEcCtD
Butenafine—Pain—Dactinomycin—kidney cancer	0.00669	0.0188	CcSEcCtD
Butenafine—Dysgeusia—Paclitaxel—kidney cancer	0.00666	0.0187	CcSEcCtD
Butenafine—SQLE—Metabolism—ALAD—kidney cancer	0.00664	0.0103	CbGpPWpGaD
Butenafine—SQLE—Metabolism—ST3GAL2—kidney cancer	0.00648	0.0101	CbGpPWpGaD
Butenafine—SQLE—Metabolism—ALDH1A1—kidney cancer	0.00634	0.00985	CbGpPWpGaD
Butenafine—Pruritus—Sorafenib—kidney cancer	0.00608	0.0171	CcSEcCtD
Butenafine—SQLE—Metabolism—SLC5A3—kidney cancer	0.00608	0.00944	CbGpPWpGaD
Butenafine—SQLE—Metabolism—PGK1—kidney cancer	0.00608	0.00944	CbGpPWpGaD
Butenafine—Pain—Vincristine—kidney cancer	0.00598	0.0168	CcSEcCtD
Butenafine—SQLE—Metabolism—LDHB—kidney cancer	0.00596	0.00926	CbGpPWpGaD
Butenafine—Pruritus—Sunitinib—kidney cancer	0.00585	0.0164	CcSEcCtD
Butenafine—Pain—Gemcitabine—kidney cancer	0.00567	0.0159	CcSEcCtD
Butenafine—Erythema—Capecitabine—kidney cancer	0.00558	0.0157	CcSEcCtD
Butenafine—Dysgeusia—Capecitabine—kidney cancer	0.00547	0.0154	CcSEcCtD
Butenafine—SQLE—Metabolism—CA9—kidney cancer	0.00517	0.00803	CbGpPWpGaD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.00505	0.00784	CbGpPWpGaD
Butenafine—Pain—Paclitaxel—kidney cancer	0.00475	0.0133	CcSEcCtD
Butenafine—Pruritus—Gemcitabine—kidney cancer	0.00469	0.0132	CcSEcCtD
Butenafine—SQLE—Metabolism—CRABP1—kidney cancer	0.00439	0.00682	CbGpPWpGaD
Butenafine—SQLE—Metabolism—ITPR2—kidney cancer	0.00408	0.00634	CbGpPWpGaD
Butenafine—Pruritus—Paclitaxel—kidney cancer	0.00393	0.011	CcSEcCtD
Butenafine—Pain—Capecitabine—kidney cancer	0.0039	0.011	CcSEcCtD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.00376	0.00585	CbGpPWpGaD
Butenafine—SQLE—Metabolism—GSTT1—kidney cancer	0.00372	0.00579	CbGpPWpGaD
Butenafine—SQLE—Metabolism—ACHE—kidney cancer	0.00372	0.00579	CbGpPWpGaD
Butenafine—Erythema—Doxorubicin—kidney cancer	0.0036	0.0101	CcSEcCtD
Butenafine—SQLE—Metabolism—SCARB1—kidney cancer	0.00352	0.00548	CbGpPWpGaD
Butenafine—Dysgeusia—Doxorubicin—kidney cancer	0.00352	0.0099	CcSEcCtD
Butenafine—SQLE—Metabolism—PTGS1—kidney cancer	0.00349	0.00542	CbGpPWpGaD
Butenafine—SQLE—Metabolism—PSMD7—kidney cancer	0.00342	0.00532	CbGpPWpGaD
Butenafine—SQLE—Metabolism—BCHE—kidney cancer	0.00324	0.00504	CbGpPWpGaD
Butenafine—Pruritus—Capecitabine—kidney cancer	0.00322	0.00906	CcSEcCtD
Butenafine—SQLE—Metabolism—SLC5A5—kidney cancer	0.0032	0.00498	CbGpPWpGaD
Butenafine—SQLE—Metabolism—SLC2A1—kidney cancer	0.00309	0.00481	CbGpPWpGaD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.003	0.00467	CbGpPWpGaD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.00262	0.00407	CbGpPWpGaD
Butenafine—SQLE—Metabolism—GSTP1—kidney cancer	0.00258	0.00401	CbGpPWpGaD
Butenafine—Pain—Doxorubicin—kidney cancer	0.00251	0.00706	CcSEcCtD
Butenafine—SQLE—Metabolism—ABCB1—kidney cancer	0.00244	0.0038	CbGpPWpGaD
Butenafine—SQLE—Metabolism—GSTM1—kidney cancer	0.00237	0.00369	CbGpPWpGaD
Butenafine—SQLE—Metabolism—CYP1A1—kidney cancer	0.00225	0.00349	CbGpPWpGaD
Butenafine—Pruritus—Doxorubicin—kidney cancer	0.00208	0.00584	CcSEcCtD
Butenafine—SQLE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.00185	0.00287	CbGpPWpGaD
Butenafine—SQLE—Metabolism—POMC—kidney cancer	0.00168	0.0026	CbGpPWpGaD
Butenafine—SQLE—Metabolism—PTGS2—kidney cancer	0.00134	0.00208	CbGpPWpGaD
Butenafine—SQLE—Metabolism—PTEN—kidney cancer	0.00117	0.00181	CbGpPWpGaD
Butenafine—SQLE—Metabolism—PIK3CA—kidney cancer	0.000823	0.00128	CbGpPWpGaD
Butenafine—Terbinafine—PTGS1—kidney cancer	0.000532	1	CrCbGaD
